Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Immunity
|
January 12, 2022
TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
Ricardo A Chaurio, Carmen M Anadon, Tara Lee Costich, et al.
Nature
|
November 4, 2021
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun, Bogang Wu, Huai-Chin Chiang, et al.
Cancer Cell
|
April 15, 2022
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
Carmen M Anadon, Xiaoqing Yu, Kay Hänggi, et al.
Aging Cell
|
April 24, 2015
Interventions to Slow Aging in Humans: Are We Ready?
Valter D Longo, Adam Antebi, Andrzej Bartke, et al.
Cancer Research
|
December 3, 2010
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer
Lyndsay V Rhodes, Sarah P Short, Nicole F Neel, et al.
Nature Medicine
|
June 13, 2024
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial
Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, et al.
Molecular Cancer
|
October 31, 2024
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors
Clare E Murray, Anand V R Kornepati, Carlos Ontiveros, et al.
Science Advances
|
October 8, 2025
Ligand-receptor interactions induce and mediate regulatory functions of BATF3<sup>+</sup> B cells
Hui Yan, Rui Wang, Suryavathi Viswanadhapalli, et al.
Cancer Immunology Research
|
November 14, 2025
The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunity
Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, et al.
Cancer Discovery
|
July 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Immunity
|
January 12, 2022
TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
Ricardo A Chaurio, Carmen M Anadon, Tara Lee Costich, et al.
Nature
|
November 4, 2021
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun, Bogang Wu, Huai-Chin Chiang, et al.
Cancer Cell
|
April 15, 2022
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
Carmen M Anadon, Xiaoqing Yu, Kay Hänggi, et al.
Aging Cell
|
April 24, 2015
Interventions to Slow Aging in Humans: Are We Ready?
Valter D Longo, Adam Antebi, Andrzej Bartke, et al.
Cancer Research
|
December 3, 2010
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer
Lyndsay V Rhodes, Sarah P Short, Nicole F Neel, et al.
Nature Medicine
|
June 13, 2024
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial
Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, et al.
Molecular Cancer
|
October 31, 2024
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors
Clare E Murray, Anand V R Kornepati, Carlos Ontiveros, et al.
Science Advances
|
October 8, 2025
Ligand-receptor interactions induce and mediate regulatory functions of BATF3<sup>+</sup> B cells
Hui Yan, Rui Wang, Suryavathi Viswanadhapalli, et al.
Cancer Immunology Research
|
November 14, 2025
The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunity
Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, et al.
Cancer Discovery
|
July 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, et al.
Page
of 15